{
  "abstract": "Thirty years ago, Sue Sheridan welcomed her first child, Cal, into the world. At 16 hours of age, a clinician observed that he was jaundiced and entered this assessment into his medical record. But Sheridan didn’t know that. She sensed something was wrong and asked repeatedly about her concerns. She was pegged as a ‘nervous mother’ and reassured. Upon discharge, the nurse’s note again described neonatal jaundice ‘from head to toe’, signalling the need for monitoring and testing. Sheridan was not informed of the potential seriousness of this condition or what symptoms to look for. On day 3, a paediatrician assessed a limp and lethargic infant. On day 4, Sheridan—still concerned—returned to the hospital. There, the bilirubin level returned at 34.6 mg/dL. Cal incurred severe brain damage from kernicterus, diagnosed months later.",
  "authors": [
    {
      "affiliations": [
        "Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA"
      ],
      "name": "Sigall K Bell"
    },
    {
      "affiliations": [
        "Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA"
      ],
      "name": "Catherine DesRoches"
    }
  ],
  "title": "Near-wins in the pursuit of quality: does transparency matter if no one is looking?",
  "uid": "3f4c546c-118c-5c42-ab12-278facc95ab2"
}